Follow
Sunil Kumar Patnaik
Sunil Kumar Patnaik
Research Scholar, JSS College of Pharmacy, Ooty
No verified email
Title
Cited by
Cited by
Year
Chemical and pharmacological evaluation of Manglicolous lichen Graphis ajarekarii PATW. & CR KULK.
P Haritha, SK Patnaik, VB Tatipamula
Vietnam Journal of Science and Technology 57 (3), 300-308, 2019
182019
Leveraging decagonal in-silico strategies for uncovering IL-6 inhibitors with precision
AK Swaroop, PKK Namboori, M Esakkimuthukumar, TK Praveen, ...
Computers in Biology and Medicine 163, 107231, 2023
82023
Targeting of ErbB1, ErbB2, and their dual targeting using small molecules and natural peptides: Blocking EGFR cell signaling pathways in cancer: A mini-review
SK Patnaik, MJN Chandrasekar, P Nagarjuna, D Ramamurthi, ...
Mini Reviews in Medicinal Chemistry 22 (22), 2831-2846, 2022
72022
Design and synthesis of novel quercetin metal complexes as IL-6 inhibitors for anti-inflammatory effect in SARS-CoV-2
AK Swaroop, SK Patnaik, J MR, PK MR
NIScPR-CSIR, India, 2022
72022
In vitro antioxidant activity and hepatoprotective potential of Ceropegia spiralis against paracetamol induced liver injury
R Kolakota, RS Kumar, SK Patnaik
Journal of Applied Pharmaceutical Science 7 (9), 199-206, 2017
62017
Evaluation of incisional diabetic wound healing activity of ethanolic leave extract of Mimosa pudica L. in rats
RS Kumar, K Rajkiran, SK Patnaik
International Journal of Pharmacognosy and Phytochemical Research 9 (08 …, 2017
62017
Virtual high throughput screening of natural peptides against ErbB1 and ErbB2 to identify potential inhibitors for cancer chemotherapy
SK Patnaik, S Ayyamperumal, D Jade, N Palathoti, KS Akey, S Jupudi, ...
Journal of Biomolecular Structure and Dynamics, 1-24, 2023
32023
Synthesis and Characterization of Dipeptide–Drug Conjugate: The Use of Linker Coupling Reaction
D Ramamurthi, J Selvaraj, SK Patnaik, N Palathoti, R Rajeshkumar, ...
International Journal of Peptide Research and Therapeutics 28 (2), 53, 2022
32022
A novel family of small molecule HIF-1 alpha stabilizers for the treatment of diabetic wounds; an integrated in silico, in vitro, and in vivo strategy
M Esakkimuthukumar, AK Swaroop, SK Patnaik, R Kumar, TK Praveen, ...
RSC advances 12 (48), 31293-31302, 2022
32022
Repurposing of FDA Approved Drugs and Neuropep peptides as Anticancer Agents Against ErbB1 and ErbB2
SK Patnaik, AK Swaroop, MR Naik, J Selvaraj, MJN Chandrasekar
Drug Research 73 (06), 341-348, 2023
22023
Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy.
SK Patnaik, AK Swaroop, P Nagarjuna, MJ Nanjan, MJN Chandrasekar
Current Molecular Pharmacology, 2023
22023
Dual modulation of IL-6 pathway by flavonoid metal complex as immune boosters for SARS-CoV-2 therapy
AK Swaroop, M Esakkimuthukumar, SK Patnaik, P Vasanth, ...
ECS Transactions 107 (1), 9771, 2022
12022
Targeting Ovarian Solid Tumors by Elastin-Like Polypeptide Drug Conjugates: Current Trends and Future Prospectives
D Ramamurthi, MJ Nanjan Chandrasekar, SB Santhosh, SK Patnaik
Current Protein and Peptide Science 22 (8), 567-573, 2021
12021
Synthesis and evaluation of novel flavonoid metal complexes as immune boosters for dual modulation of IL-6 pathway in SARS-CoV-2 therapy; A combined in-silico and in-vitro …
SK Patnaik, P Vasanth, P Kumar, N Jawahar, J Selvaraj
2022
Insilico Invitro and Invivo Assessment of Natural Peptides towards Dual Targeting of ErbB1 and ErbB2 in Cancer Chemotherapy
SK Patnaik
Mysore, 0
The system can't perform the operation now. Try again later.
Articles 1–15